Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Exscientia (NASDAQ:EXAI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings. Profitability This table compares Anavex Life Sciences […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Exscientia (NASDAQ:EXAI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Valuation & Earnings This table compares Anavex […]
Anavex Life Sciences Corp. announced the addition and appointment of new senior team members with a track record of successfully bringing drugs to market. Reinforcing the Company?s commitment to drive.
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
New York State Common Retirement Fund boosted its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,321 shares of the biotechnology company’s stock after acquiring an additional 2,670 […]